Aparna Ramasubramanian MD
Director, Retinoblastoma Program, Children's Wisconsin, Milwaukee, WisconsinDr. Aparna Ramasubramanian is the medical director of the Wisconsin Children's retinoblastoma program. An expert in the field of ocular oncology in the United States, Dr. Ramasubramanian has very unique training as a dual fellowship-trained physician in both pediatric ophthalmology and ocular oncology. Dr. Ramasubramanian is the author of the leading textbook on retinoblastoma and has published extensively in peer reviewed journal. She received the American Academy of Ophthalmology Achievement Award in 2018 and the Knights Templar Research Award for her research in retinoblastoma.
Disclosures
Dr. Ramasubramanian reports no financial disclosures.Recent Contributions to PracticeUpdate:
- Effects of Fetal Haemoglobin on Systemic Oxygenation in Preterm Infants and the Development of Retinopathy of Prematurity
- Prenatal Maternal Characteristics Associated With Retinopathy of Prematurity Development in Infants
- Refractive Status, Biometric Components, and Functional Outcomes in Patients With Threshold Retinopathy of Prematurity
- 2022 Top Story in Eye Care: Bevacizumab in the Treatment of Retinopathy of Prematurity
- Prevalence and Risk Factors of Hypothalamus–Pituitary–Adrenal Axis Suppression in Infants Receiving Glucocorticoid Eye Drops After Ocular Surgery
- Outcomes of Low-Dose vs Very Low–Dose Bevacizumab Treatment in Infants With Retinopathy of Prematurity
- Childhood Amblyopia: Importance of Detecting Early
- Choroidal Nevi: 8 Risk Factors
- Retinal Development in Infants and Young Children With Albinism
- Primary IOL Implantation in Infants With Unilateral Congenital Cataract Operated Before 12 Weeks of Age